1. Home
  2. THM vs SLN Comparison

THM vs SLN Comparison

Compare THM & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Tower Hill Mines Ltd. (Canada)

THM

International Tower Hill Mines Ltd. (Canada)

N/A

Current Price

$2.41

Market Cap

722.1M

Sector

N/A

ML Signal

N/A

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

N/A

Current Price

$9.95

Market Cap

678.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
THM
SLN
Founded
1978
1994
Country
Canada
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
722.1M
678.0M
IPO Year
2002
2010

Fundamental Metrics

Financial Performance
Metric
THM
SLN
Price
$2.41
$9.95
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
★ $33.00
AVG Volume (30 Days)
644.7K
★ 885.1K
Earning Date
11-06-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $559,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$132.77
P/E Ratio
$280.00
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.43
$4.19
52 Week High
$3.65
$17.58

Technical Indicators

Market Signals
Indicator
THM
SLN
Relative Strength Index (RSI) 45.15 30.63
Support Level $2.21 $4.70
Resistance Level $2.44 $11.06
Average True Range (ATR) 0.12 0.58
MACD -0.04 -0.16
Stochastic Oscillator 24.03 26.27

Price Performance

Historical Comparison
THM
SLN

About THM International Tower Hill Mines Ltd. (Canada)

International Tower Hill Mines Ltd is a mining company. It is engaged in the acquisition, exploration, and development of mineral properties. The company holds interests in an exploration project, namely the Livengood Gold Project. It is located in the northwest of Fairbanks, Alaska, in the Tolovana mining district within the Tintina gold belt. The project property consists of land leased from the Alaska Mental Health Trust, several smaller private mineral leases, Alaska state mining claims purchased or located by the company, and the patented ground held by the company.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: